MAPT and neurodegenerative disease: Our results in the present study suggest that PGRN reduction may cause tau and α-syn accumulation by impairing GCase activity and increasing GlcCer levels in FTLD-GRN and in other neurodegenerative diseases, consistent with a large body of literature showing an association between GCase and synucleinopathy45,46.